Security key
363225202
GALECTIN THERAPEUTICS INC - COMMON STOCK (GALT)
CUSIP: 363225202
Q1 2026 13F Holders as of 31 Mar 2026
- Security type / class
- Equity / COMMON STOCK
- Total 13F shares
- 13,871,572
- Total 13F value
- $38,563,609
- Share change
- +2,308,289
- Put/Call ratio
- 5.6%
- SEC-reported price per share
- $2.79
- Number of holders
- 98
- Value change
- +$5,713,069
- Number of buys
- 47
- Number of sells
- 37
- Shares outstanding
- 110,899,890
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2026
Institutions
98
Top holders
10
GALT full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q2 2026
GALECTIN THERAPEUTICS INC SEC filings
GALECTIN THERAPEUTICS INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 363225202
Recent filing periods:
Ownership snapshot
Top reported holders of GALT - GALECTIN THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
10X Fund, L.P.
Disclosed value leader
10X Fund, L.P.
Comparable rows
15/15
Latest evidence
31 Dec 2025
3/4/5
13F
Lead comparable stake: 5.1%
Showing 1-6 of 15 holder rows.
Quick read
10X Fund, L.P. leads the comparable SEC ownership view at 5.1%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 10X Fund, L.P.'s linked filing trail.
Comparable ownership
Top 5
10X Fund, L.P.
5.1%
James C. Czirr
0.94%
VANGUARD GROUP INC
2.1%
OSAIC HOLDINGS, INC.
0.98%
BlackRock, Inc.
0.72%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 10X Fund, L.P. |
3/4/5
10%+ Owner
|
5.1%
|
$37,392,283
5,614,457 shares
|
-$1,581,991 | 02 Dec 2025 |
| James C. Czirr |
3/4/5
10%+ Owner
|
0.94%
|
$1,160,550
1,045,541 shares
|
— | 03 Feb 2025 |
| VANGUARD GROUP INC |
13F
Company
|
2.1%
|
$9,521,608
2,288,848 shares
|
— | 31 Dec 2025 |
| OSAIC HOLDINGS, INC. |
13F
Company
|
0.98%
|
$4,536,850
1,090,590 shares
|
— | 31 Dec 2025 |
| BlackRock, Inc. |
13F
Company
|
0.72%
|
$3,313,681
796,558 shares
|
— | 31 Dec 2025 |
| MARSHALL WACE, LLP |
13F
Company
|
0.54%
|
$2,504,877
602,134 shares
|
— | 31 Dec 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2026
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
98
Shares
13,871,572
Rows available
98
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2026 vs Q1 2026 Across Filers
Q1 2026 holders
98
Q1 2026 holders
98
Holder diff
0
| Investor | Q1 2026 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q1 2026 value | Q1 2026 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend